Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Improving the outlook for myelodysplastic syndrome.

Brower V.

J Natl Cancer Inst. 2012 Aug 22;104(16):1204-6. doi: 10.1093/jnci/djs368. Epub 2012 Aug 16. No abstract available.

PMID:
22899627
[PubMed - indexed for MEDLINE]
Free Article
2.

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study.

Platzbecker U, Braulke F, Kündgen A, Götze K, Bug G, Schönefeldt C, Shirneshan K, Röllig C, Bornhäuser M, Naumann R, Neesen J, Giagounidis A, Hofmann WK, Ehninger G, Germing U, Haase D, Wermke M.

Leukemia. 2013 Jun;27(6):1403-7. doi: 10.1038/leu.2013.26. Epub 2013 Jan 28. No abstract available.

PMID:
23354011
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Molecular target therapy for myelodysplastic syndrome].

Morita Y, Tanaka H, Matsumura I.

Nihon Rinsho. 2012 Nov;70 Suppl 8:508-12. Japanese. No abstract available.

PMID:
23513892
[PubMed - indexed for MEDLINE]
4.

Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.

Estey EH.

Leukemia. 2013 Sep;27(9):1803-12. doi: 10.1038/leu.2013.173. Epub 2013 Jun 12. Review.

PMID:
23757301
[PubMed - indexed for MEDLINE]
5.

[Hypomethylating agents for the treatment of myelodysplastic syndromes].

Itzykson R, Fenaux P.

Bull Cancer. 2011 Aug;98(8):927-34. doi: 10.1684/bdc.2011.1411. Review. French.

PMID:
21821482
[PubMed - indexed for MEDLINE]
6.

Epigenetic therapies move into new territory, but how exactly do they work?

Tuma RS.

J Natl Cancer Inst. 2009 Oct 7;101(19):1300-1. doi: 10.1093/jnci/djp342. Epub 2009 Sep 15. No abstract available.

PMID:
19755677
[PubMed - indexed for MEDLINE]
Free Article
7.

[Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].

Daskalakis M, Blagitko-Dorfs N, Hackanson B, Lübbert M.

Pharm Unserer Zeit. 2010 May;39(3):217-27. doi: 10.1002/pauz.201000369. Review. German. No abstract available.

PMID:
20425776
[PubMed - indexed for MEDLINE]
8.

[5-day decitabine for treatment of myelodysplastic syndromes with complex karyotype abnormalities and acute myeloid leukemia].

Gao S, Hu XH, Qiu HY, Xu Y, Jin ZM, He GS, Tang XW, Han Y, Chen SN, Sun AN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2013 Jun;34(6):542-3. doi: 10.3760/cma.j.issn.0253-2727.2013.06.019. Chinese. No abstract available.

PMID:
23827117
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical development of demethylating agents in hematology.

Navada SC, Steinmann J, Lübbert M, Silverman LR.

J Clin Invest. 2014 Jan 2;124(1):40-6. doi: 10.1172/JCI69739. Epub 2014 Jan 2. Review.

PMID:
24382388
[PubMed - indexed for MEDLINE]
10.

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.

Abáigar M, Ramos F, Benito R, Díez-Campelo M, Sánchez-del-Real J, Hermosín L, Rodríguez JN, Aguilar C, Recio I, Alonso JM, de las Heras N, Megido M, Fuertes M, del Cañizo MC, Hernández-Rivas JM.

Ann Hematol. 2013 Nov;92(11):1543-52. doi: 10.1007/s00277-013-1799-9. Epub 2013 Jun 6.

PMID:
23740492
[PubMed - indexed for MEDLINE]
11.

Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML.

Ettou S, Audureau E, Humbrecht C, Benet B, Jammes H, Clozel T, Bardet V, Lacombe C, Dreyfus F, Mayeux P, Solary E, Fontenay M.

Leukemia. 2012 Oct;26(10):2297-9. doi: 10.1038/leu.2012.152. Epub 2012 Jun 5. No abstract available.

PMID:
22743624
[PubMed - indexed for MEDLINE]
12.

New agents in the treatment of MDS.

List AF.

Clin Adv Hematol Oncol. 2005 Nov;3(11):832-4. No abstract available.

PMID:
16491623
[PubMed - indexed for MEDLINE]
13.

[Deregulated splicing machinery in myelodysplastic syndromes].

Ogawa S.

Rinsho Ketsueki. 2012 May;53(5):493-6. Review. Japanese. No abstract available.

PMID:
22728550
[PubMed - indexed for MEDLINE]
14.

Targeting DNA methylation.

Issa JP, Kantarjian HM.

Clin Cancer Res. 2009 Jun 15;15(12):3938-46. doi: 10.1158/1078-0432.CCR-08-2783. Epub 2009 Jun 9.

PMID:
19509174
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.

[No authors listed]

Clin Adv Hematol Oncol. 2005 Mar;3(3 Suppl 1):1-10; quiz 11-2. Review. No abstract available.

PMID:
21438190
[PubMed - indexed for MEDLINE]
16.

[New tools and treatments in myelodysplastic syndromes].

Cluzeau T, Fenaux P.

Rev Med Interne. 2013 Mar;34(3):159-67. doi: 10.1016/j.revmed.2012.06.009. Epub 2012 Jul 4. Review. French.

PMID:
22766158
[PubMed - indexed for MEDLINE]
17.

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.

Itzykson R, Kosmider O, Cluzeau T, Mansat-De Mas V, Dreyfus F, Beyne-Rauzy O, Quesnel B, Vey N, Gelsi-Boyer V, Raynaud S, Preudhomme C, Adès L, Fenaux P, Fontenay M; Groupe Francophone des Myelodysplasies (GFM).

Leukemia. 2011 Jul;25(7):1147-52. doi: 10.1038/leu.2011.71. Epub 2011 Apr 15.

PMID:
21494260
[PubMed - indexed for MEDLINE]
18.

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP.

Blood. 2012 Apr 5;119(14):3203-10. doi: 10.1182/blood-2011-12-399774. Epub 2012 Feb 9.

PMID:
22323480
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Epigenetic therapy with decitabine for myelodysplasia and leukemia.

Wijermans P, Lübert M.

Future Oncol. 2005 Oct;1(5):585-91. Review.

PMID:
16556035
[PubMed - indexed for MEDLINE]
20.

Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.

Baylin SB, Mufti GJ.

Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S1-3. No abstract available.

PMID:
16341235
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk